BRTX
BioRestorative Therapies Inc
NASDAQ: BRTX · HEALTHCARE · BIOTECHNOLOGY
$0.23
+11.60% today
Updated 2026-04-30
Market cap
$5.86M
P/E ratio
—
P/S ratio
16.28x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$0 – $2
Volume
10.4M
BioRestorative Therapies Inc (BRTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | $-729218.00 | $-2.81M | $-3.18M | $-2.67M | $-3.23M | $-3.12M | $-5.00M | $-3.85M | $-5.10M | $-6.92M | $-1.96M | $-3.33M | $-5.91M | $-6.43M | $-8.23M | $-10.79M |
| Capital expenditures | $112000.00 | $48784.00 | $17772.00 | $1.00M | $11160.00 | $168376.00 | $483069.00 | $188764.00 | $3617.00 | $12869.00 | $35631.00 | $35631.00 | $30658.00 | $440223.00 | $171043.00 | $106189.00 | $116067.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $895608.00 | $456826.00 | $1.85M | $812647.00 | $1.36M | $1.95M | $2.54M | $3.60M | $2.40M | $1.66M | $691701.00 | $23.11M | $12.61M | $7.78M | $2.81M | $3.33M |
| Free cash flow | — | $-778002.00 | $-2.83M | $-4.19M | $-2.68M | $-3.40M | $-3.61M | $-5.19M | $-3.86M | $-5.12M | $-6.95M | $-2.00M | $-3.36M | $-6.35M | $-6.60M | $-8.34M | $-10.91M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $569068.00 | $623801.00 | $270573.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | $3.56M | — | — | — | — | — |